Pan-immune-inflammation value as a novel predictor of pathological response to neoadjuvant chemotherapy combined with anti-PD-1 therapy in esophageal squamous cell carcinoma: a multicenter real-world retrospective clinical study.
Saved in:
| Title: | Pan-immune-inflammation value as a novel predictor of pathological response to neoadjuvant chemotherapy combined with anti-PD-1 therapy in esophageal squamous cell carcinoma: a multicenter real-world retrospective clinical study. |
|---|---|
| Authors: | Huang JS; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, China.; Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, China.; National Key Clinical Specialty of Thoracic Surgery, Fuzhou, China.; Clinical Research Center for Thoracic Tumors of Fujian Province, Fuzhou, China., Zhong QH; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, China.; Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, China.; National Key Clinical Specialty of Thoracic Surgery, Fuzhou, China.; Clinical Research Center for Thoracic Tumors of Fujian Province, Fuzhou, China., Wang G; Department of Thoracic Surgery, GanZhou Cancer Hospital, Ganzhou, China., Tang ZL; Department of Thoracic Surgery, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China., Shen BL; Department of Thoracic Surgery, Anxi County Hospital, Quanzhou, China., Liu WN; Department of Thoracic Surgery, Quanzhou Guangqian Hospital, Quanzhou, China., Guo FL; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, China.; Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, China.; National Key Clinical Specialty of Thoracic Surgery, Fuzhou, China.; Clinical Research Center for Thoracic Tumors of Fujian Province, Fuzhou, China., Wu JY; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, China.; Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, China.; National Key Clinical Specialty of Thoracic Surgery, Fuzhou, China.; Clinical Research Center for Thoracic Tumors of Fujian Province, Fuzhou, China., Zhang ZY; Department of Thoracic Surgery, Fujian Medical University Union Hospital, No. 29 Xinquan Road, Fuzhou 350001, China Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, China.; National Key Clinical Specialty of Thoracic Surgery, Fuzhou, China.; Clinical Research Center for Thoracic Tumors of Fujian Province, Fuzhou, China., Lin JB; Department of Thoracic Surgery, Fujian Medical University Union Hospital, No. 29 Xinquan Road, Fuzhou 350001, China Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, China.; National Key Clinical Specialty of Thoracic Surgery, Fuzhou, China.; Clinical Research Center for Thoracic Tumors of Fujian Province, Fuzhou, China. |
| Source: | Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2025 Oct 31; Vol. 17, pp. 17588359251378883. Date of Electronic Publication: 2025 Oct 31 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1758-8340 |
|---|---|
| DOI: | 10.1177/17588359251378883 |
